Patents by Inventor Pei-Chun Kuo

Pei-Chun Kuo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9833436
    Abstract: A method of preparing drug agglomerates includes adding a drug powder to a first solvent to form a first solution, adding a second solvent to the first solution to form a second solution. The drug powder undergoes nucleation to form drug agglomerates. The drug agglomerates are isolated from the second solution.
    Type: Grant
    Filed: April 28, 2017
    Date of Patent: December 5, 2017
    Assignee: PharmaDax Inc.
    Inventors: Pei-Chun Kuo, Shih-Wei Huang, Chiung-Fang Chang
  • Publication number: 20170224655
    Abstract: A method of preparing drug agglomerates includes adding a drug powder to a first solvent to form a first solution, adding a second solvent to the first solution to form a second solution. The drug powder undergoes nucleation to form drug agglomerates. The drug agglomerates are isolated from the second solution.
    Type: Application
    Filed: April 28, 2017
    Publication date: August 10, 2017
    Inventors: Pei-Chun KUO, Shih-Wei HUANG, Chiung-Fang CHANG
  • Patent number: 9668975
    Abstract: A method of preparing drug agglomerates includes adding a drug powder to a first solvent to form a first solution, adding a second solvent to the first solution to form a second solution. The drug powder undergoes nucleation to form drug agglomerates. The drug agglomerates are isolated from the second solution.
    Type: Grant
    Filed: October 13, 2015
    Date of Patent: June 6, 2017
    Assignee: PharmaDax Inc.
    Inventors: Pei-Chun Kuo, Shih-Wei Huang, Chiung-Fang Chang
  • Publication number: 20160101055
    Abstract: A method of preparing drug agglomerates includes adding a drug powder to a first solvent to form a first solution, adding a second solvent to the first solution to form a second solution. The drug powder undergoes nucleation to form drug agglomerates. The drug agglomerates are isolated from the second solution.
    Type: Application
    Filed: October 13, 2015
    Publication date: April 14, 2016
    Inventors: Pei-Chun KUO, Shih-Wei HUANG, Chiung-Fang CHANG
  • Publication number: 20100104651
    Abstract: A once-daily controlled-release formulation of diacerein for treating inflammatory or autoimmune diseases or their complications, with reduced adverse side effects and methods of treating such diseases are disclosed.
    Type: Application
    Filed: October 28, 2009
    Publication date: April 29, 2010
    Inventors: Danchen Gao, Jen-Sen Wu, Wei-Shu Lu, Shouchiung Chen, Pei-Chun Kuo, Chih-Ming Chen
  • Publication number: 20070014858
    Abstract: An osmotically controlled delivery system includes a solid core having a shallow indentation on a surface of the core, and a semipermeable membrane enclosing the solid core. The solid core is made by a drug composition being caopable of generating an osmotically effective pressure, and the semipermeable membrane is relatively thinner at the shallow indentation. An in-situ exit passageway is formed in the indentation position when external aqueous fluids are imbibed through the semipermeable membrane into the dosage form by an osmotic pressure gradient. A process for forming an in-situ exit passageway of an osmotic delivery dosage form, a controlled onset dosage form, and a method for controlling the lag time of in-situ passageway formation are also disclosed.
    Type: Application
    Filed: July 6, 2006
    Publication date: January 18, 2007
    Inventors: Jen-Sen Wu, Yih-Yih Lin, Shou-Chiung Chen, Yi-Pin Huang, Hui-Ju Chan, Pei-Chun Kuo, Chun-Yu Lin